0

Guidelines C

Guidelines C

Caesarean Section

Campylobacter

Cancer Of The Anus

Cancer Of The Bile Duct

Cancer Of The Bladder

Cancer Of The Bone

Cancer Of The Bowel

Cancer Of The Breast

Cancer Of The Cervix

Cancer Of The Head And Neck

Cancer Of The Kidney

Cancer Of The Liver

Cancer Of The Lung

Cancer Of The Oesophagus

Cancer Of The Ovary

Cancer Of The Pancreas

Cancer Of The Penis

Cancer Of The Peritoneum

Cancer Of The Prostate

Cancer Of The Skin

Cancer Of The Stomach

Cancer Of The Testis

Cancer Of The Thyroid

Cancer Of The Vulva

Cancers

  • 111In-Pentetreotide Scintigraphy – Procedure Guidelines for Tumour Imaging European Association of Nuclear Medicine (2003)
  • 131I/123I-Metaiodobenzylguanidine (MIBG) Scintigraphy – Procedure Guidelines for Tumour Imaging European Association of Nuclear Medicine (2003)
  • Advanced breast cancer NICE Clinical Guideline (February 2009)
  • Advanced colorectal cancer: ESMO Clinical Practice Guidelines for treatment European Society for Medical Oncology (2010)
  • Anaemia (cancer-treatment induced) – erythropoietin (alpha and beta) and darbepoetin NICE Technology Appraisal Guidance (May 2008)
  • Anal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up European Society for Medical Oncology (2010)
  • Best Practice Statement: Skincare of Patients Receiving Radiotherapy NHS Quality Improvement Scotland (2004)
  • Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up European Society for Medical Oncology (2011)
  • Bladder cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up European Society for Medical Oncology (2011)
  • Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up European Society for Medical Oncology (2010)
  • Bone Scintigraphy – Procedure Guidelines for Tumour Imaging European Association of Nuclear Medicine (2003)
  • Brain cancer – temozolomide NICE (2001)
  • Breast cancer – vinorelbine NICE (2002)
  • Breast cancer (early) – hormonal treatments NICE Technology appraisal (2006)
  • Cancer, fertility and pregnancy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up European Society for Medical Oncology (2010)
  • Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up European Society for Medical Oncology (2011)
  • Cardiotoxicity of chemotherapeutic agents and radiotherapy-related heart disease: ESMO Clinical Practice Guidelines European Society for Medical Oncology (2010)
  • Cervical cancer – cervical screening NICE Technology Appraisal (Oct 2003)
  • Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up European Society for Medical Oncology (2010)
  • Chemotherapy Services in England: ensuring quality and safety Dept of Health (August 2009)
  • Children’s tumours – suspected Clinical Knowledge Summaries (2000)
  • Control of pain in adults with cancer Scottish Intercollegiate Guidelines Network – SIGN (November 2008)
  • Cutaneous Melanoma Scottish Intercollegiate Guidelines Network – SIGN (2003)
  • Cytoreduction surgery followed by hyperthermic intraoperative peritoneal chemotherapy for peritoneal carcinomatosis NICE Interventional Procedure Guideline (February 2010)
  • Early and locally advanced breast cancer NICE Clinical Guideline (February 2009)
  • Early stage and locally advanced (non-metastatic) non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up European Society for Medical Oncology (2010)
  • EFNS Guidelines on diagnosis and treatment of brain metastases: report of an EFNS Task Force European Federation of Neurological Societies (2006)
  • Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up European Society for Medical Oncology (2011)
  • Epithelial ovarian cancer Scottish Intercollegiate Guidelines Network – SIGN (2003)
  • Erythropoiesis-stimulating agents in the treatment of anaemia in cancer patients: ESMO Clinical Practice Guidelines for use European Society for Medical Oncology (2010)
  • Esophageal cancer: Clinical Practice Guidelines for diagnosis, treatment and follow-up European Society for Medical Oncology (2010)
  • Familial breast cancer NICE Clinical Guideline (October 2006)
  • FDG-PET – Procedure Guidelines for Tumour Imaging European Association of Nuclear Medicine (2003)
  • GA Scintigraphy – Procedure Guidelines for Tumour Imaging European Association of Nuclear Medicine (2003)
  • Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up European Society for Medical Oncology (2010)
  • Gastro-intestinal stromal tumours (GIST) – imatinib NICE Technology Appraisal (2004)
  • Gastrointestinal stromal tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up European Society for Medical Oncology (2010)
  • Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference European Society for Medical Oncology (2010)
  • Guidelines and best practice statements for oncologists and radiotherapists (various) Royal College of Radiologists (various dates)
  • Guidelines for 18F-FDG PET and PET-CT imaging in paediatric oncology European Association of Nuclear Medicine (2008)
  • Guidelines for HIV-associated malignancies British HIV Association (July 2008)
  • Guidelines for resection of colorectal cancer liver metastases British Society of Gastroenterology (2006)
  • Guidelines for the Diagnosis and Treatment of Cholangiocarcinoma British Society of Gastroenterology (2002)
  • Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (HCC) in adults British Society of Gastroenterology (2003)
  • Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs) British Society of Gastroenterology (2012)
  • Guidelines for the management of oesophageal and gastric cancer British Society of Gastroenterology (June 2011)
  • Guidelines for the management of patients with pancreatic cancer periampullary and ampullary carcinomas British Society of Gastroenterology (2005)
  • Guidelines for the Management of the Patient with Primary Cutaneous Squamous Cell Carcinoma British Association of Dermatologists (2009)
  • Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up European Society for Medical Oncology (2010)
  • Improving outcomes for people with sarcoma NICE (2006)
  • Improving Outcomes for People with Skin Tumours including Melanoma, NICE (Update May 2010)
  • Improving outcomes in breast cancer NICE Clinical Guideline (2002)
  • Improving outcomes in haemato-oncology cancer NICE Cancer Service Guidance (2003)
  • Improving outcomes in head and neck cancers NICE (2004)
  • Improving outcomes in urological cancers NICE Cancer Service Guidance (2002)
  • Improving outcomes with children and young people with cancer NICE Cancer Service Guidance (2005)
  • Interstitial laser therapy for breast cancer NICE (2004)
  • Key recommendations and overview of management of thyroid cancer (differentiated and medullary) Royal College of Physicians (2002)
  • Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up European Society for Medical Oncology (2011)
  • Long term follow up care of survivors of childhood cancers Scottish Intercollegiate Guidelines Network – SIGN (2004)
  • Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up European Society for Medical Oncology (2010)
  • Management of cancer pain: ESMO Clinical Practice Guidelines European Society for Medical Oncology (2011)
  • Management of cervical cancer Scottish Intercollegiate Guidelines Network – SIGN (January 2008)
  • Management of colorectal cancer Scottish Intercollegiate Guidelines Network – SIGN (2003)
  • Management of febrile neutropenia: ESMO Clinical Practice Guidelines European Society for Medical Oncology (2010)
  • Management of oral and gastrointestinal mucositis: ESMO Clinical Practice Guidelines European Society for Medical Oncology (2011)
  • Management of patients with lung cancer Scottish Intercollegiate Guidelines Network – SIGN (2005)
  • Management of venous thromboembolism (VTE) in cancer patients: ESMO Clinical Practice Guidelines European Society for Medical Oncology (2011)
  • Manual for Cancer Services 2008: complementary therapy (safeguarding practice) measures Dept of Health (October 2009)
  • Melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up European Society for Medical Oncology (2010)
  • Mesothelioma – pemetrexed disodium NICE Technology Appraisal (January 2008)
  • Metastatic malignant disease of unknown primary origin NICE Clinical Guideline (July 2010)
  • Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up European Society for Medical Oncology (2010)
  • Mouth care for children and young people with cancer – evidence-based guidelines UKCCSG-PONF Mouth Care Group (February 2006)
  • Multi-disciplinary Guidelines for the Oral Management of Patients following Oncology Treatment British Society for Disability and Oral Health (no date)
  • Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up European Society for Medical Oncology (2010)
  • Multi-professional guidelines for the management of the patient with primary cutaneous squamous cell carcinoma British Association of Dermatologists (2009)
  • Nasopharyngeal cancer: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up European Society for Medical Oncology (2010)
  • Neuroendocrine bronchial and thymic tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up European Society for Medical Oncology (2010)
  • Neuroendocrine gastroenteropancreatic tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up European Society for Medical Oncology (2010)
  • Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up European Society for Medical Oncology (2010)
  • Non-epithelial ovarian cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up European Society for Medical Oncology (2010)
  • Ovarian cancer – paclitaxel NICE (2003)
  • Ovarian cancer (advanced) – paclitaxel, pegylated liposomal doxorubicin hydrochloride and topotecan NICE Technology Appraisal (2005)
  • Pancreatic cancer – gemcitabine NICE Technology Appraisal (2001)
  • Pancreatic cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up European Society for Medical Oncology (2010)
  • Percutaneous cementoplasty for palliative treatment of bony malignancies NICE (2006)
  • Practice guidance on the management of acute and chronic gastrointestinal problems arising as a result of treatment for cancer British Society of Gastroenterology (2011)
  • Practice Guidance: bowel cancer Royal Pharmaceutical Society of Great Brtitain (May 2007)
  • Pregnancy and breast cancer Royal College of Obstretricians and Gynaecologists (April 2011)
  • Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up European Society for Medical Oncology (2011)
  • Primary colon cancer: ESMO Clinical Practice Guidelines for diagnosis, adjuvant treatment and follow-up European Society for Medical Oncology (2010)
  • Procedure guideline for treatment of refractory metastatic bone pain European Association of Nuclear Medicine (2008)
  • Prostate cancer NICE Clinical Guideline (February 2008)
  • Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up European Society for Medical Oncology (2010)
  • Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up European Society for Medical Oncology (2010)
  • Referral for suspected cancer NICE Clinical Guideline (2005)
  • Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up European Society for Medical Oncology (2010)
  • Service guidance for the NHS in England and Wales Improving Outcomes for Colorectal Cancer (update) NICE (2004)
  • Skin cancer – suspected Clinical Knowledge Summaries (2007)
  • Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up European Society for Medical Oncology (2010)
  • Soft tissue sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up European Society for Medical Oncology (2010)
  • Squamous cell carcinoma of the head and neck: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up European Society for Medical Oncology (2010)
  • Testicular non-seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up European Society for Medical Oncology (2010)
  • Testicular seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up European Society for Medical Oncology (2010)
  • The effects of cancer treatment on reproductive functions: guidance on management Royal College of Radiologists et al (November 2007)
  • The National End of Life Care Programme, Dept of Health 2009
  • Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up European Society for Medical Oncology (2010)
  • Updated national guidance on the safe administration of intrathecal chemotherapy Dept of Health (August 2008)
  • Urological cancer – suspected Clinical Knowledge Summaries (2000)

Cancers And Other Tumours (oncology)

Candida

Carbon Monoxide Poisoning

Carbuncles

Carcinoid Tumor

Cardiac Arrest

Cardiac Rehabilitation

Cardiomyopathy

Cardiovascular Risk Assessment

Caries

Carotid Artery Disease

Carpal Tunnel Syndrome

Cartilage Injury

Cataract

Cataracts

Cellulitis

Cerebral Palsy

Cerebral Thromboembolism

Cerebral Venous Sinus Thrombosis

Certificates

Cervical Cancer

Cervical Cancer Screening

Cervical Cerclage

Cervical Radiculopathy

Cervical Spine Lesion

Cervical Spondylosis

Chalazion

Chancroid

Chemotherapy Drugs

Chest Infection

Chest/lung

Chickenpox

Chilblains

Child Abuse

Child Development

Child Health

Childbirth

Childhood Cancer

Childhood Immunisations

Chlamydia (genital)

Chlamydia Infection

Cholangiocarcinoma

Cholecystectomy

Cholecystitis

Cholestasis Of Pregnancy

Cholesterol Level

Chronic Alcoholism

Chronic Daily Headache

Chronic Fatigue Syndrome

Chronic Kidney Disease

Chronic Obstructive Pulmonary Disease (copd)

Chronic Pancreatitis

Chronic Pelvic Pain

Chronic Renal Failure

Chronic Sinusitis

Churg-strauss Syndrome

Cimicifuga Racemosa

Circumcision

  • Management of foreskin conditions Statement from the British Association of Paediatric Urologists on behalf of the British
    Association of Paediatric Surgeons and The Association of Paediatric Anaesthetists (2007)

Cirrhosis

Clostridium

Clostridium Difficile

Clotting Disorder

Cluster Headache

Coarctation Of Aorta

Cocaine Abuse

Cocaine Addiction

Cochlear Implants

Coeliac Disease

Cognitive Behavioral Therapy

Cold Sores

Colic

Collagen Injections

Colon Cancer

Colonic Polyps

Colonoscopy

Colorectal Carcinoma

Colostomy

Colposcopy

Coma

Combined Oral Contraceptives (coc)

Common Cold

Complementary Therapies

Conduct Disorder

Congenital Adrenal Hyperplasia

Congenital Heart Disease

Conjunctivitis

Constipation

Contact Dermatitis

Contraception

Contraceptive Patch

Controlled Drugs

Coordination Poor

Corneal Graft

Corneal Problems

Corneal Superficial Injury

Coronary Angioplasty

Coronary Artery Bypass Surgery

Coronary Artery Stent

Coronary Heart Disease

Coronary Syndrome

Corticosteroids

Cosmetic Surgery

Cot Death

Cough

Counselling

Craniopharyngioma

Creatine Kinase

Creutzfeldt-jakob Disease

Crohn’s Disease

Croup

  • Croup Prodigy (September 2008)

Cruciate Ligament Tears

Cryptorchism (bilateral)

Ct Scan

Cyclical Breast Pain

Cystectomy

Cystic Fibrosis

Cystitis

Cytomegalovirus Encephalitis

Provide feedback

Egton Medical Information Systems Limited. Registered in England. No 2117205 Registered Office: Fulford Grange, Micklefield Lane, Rawdon, Leeds, LS19 6BA

admin

Leave a Reply

Your email address will not be published. Required fields are marked *